GeneralBullishBlockonomi · 4h ago6/10
📰
Eli Lilly (LLY) Stock Surges 4% After CVS Reverses Zepbound Coverage Decision
Eli Lilly's stock rose 4% following CVS Caremark's decision to reverse its prior exclusion of Zepbound, now covering both Eli Lilly's weight-loss drugs alongside competitor Novo Nordisk's products. This policy reversal signals expanding insurance coverage for GLP-1 medications and validates Eli Lilly's competitive position in the rapidly growing obesity treatment market.